<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03794479</url>
  </required_header>
  <id_info>
    <org_study_id>travellers_version 2_20180724</org_study_id>
    <nct_id>NCT03794479</nct_id>
  </id_info>
  <brief_title>Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel</brief_title>
  <official_title>Changes in Intestinal Microbiota and Acquisition of Antimicrobial Resistance in Hong Kong Residents After Travel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      International travel is well reported to be associated with acquisition of
      multidrug-resistant organisms, however, the impact of colonization of these
      multidrug-resistant organisms is currently uncertain. As colonization of multidrug-resistant
      organisms had been demonstrated to be associated with distinct intestinal microbiota
      composition and travellers constitute a generally healthy population with minimal antibiotics
      exposure; by evaluating serial stool samples before and after travel, we can delineate a
      potential causal relationship between host intestinal microbiota and subsequent risk of
      acquisition of multidrug-resistant organisms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients acquiring intestinal colonization of ESBL-producing Enterobacteriaceae</measure>
    <time_frame>1 year</time_frame>
    <description>Intestinal colonization of ESBL-producing Enterobacteriaceae is defined as the presence of ESBL in Enterobacteriaceae identified in the post-travel stool samples, in patients without these organisms detected in their stool samples before travel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients acquiring intestinal colonization of carbapenem-resistant Enterobacteriaceae</measure>
    <time_frame>1 year</time_frame>
    <description>Intestinal colonization of carbapenem-resistant Enterobacteriaceae is defined as the presence of carbapenem-resistant Enterobacteriaceae identified in the stool samples, in patients without these organisms detected in their stool samples before travel.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Antimicrobial Resistance</condition>
  <arm_group>
    <arm_group_label>Travellers</arm_group_label>
    <description>Adults planning for travel</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults planning for travel
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults aged 18 years or above

          -  Chinese ethnicity

          -  Planning to visit any places outside of Hong Kong within the next three months

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Use of antibiotics within 4 weeks prior to the time of recruitment (Except for
             antimalarial prophylaxis)

          -  Hospitalization within 3 months

          -  Underlying gastrointestinal diseases, including gastrointestinal malignancy,
             inflammatory bowel disease, resection of small or large bowel

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Sha Tin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Lui</last_name>
      <phone>35053376</phone>
      <email>gracelui@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Rity Wong</last_name>
      <phone>35053376</phone>
      <email>ritywong@cuhk.edu.hk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 3, 2019</study_first_submitted>
  <study_first_submitted_qc>January 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2019</study_first_posted>
  <last_update_submitted>January 3, 2019</last_update_submitted>
  <last_update_submitted_qc>January 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Grace Lui</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Intestinal microbiota</keyword>
  <keyword>Antimicrobial resistance</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

